<正>1文献来源Cheng Y,Yang JC,Okamoto I,et al. Pembrolizumab plus chemotherapy for advanced non-small-cell lung cancer without tumor PD-L1 expression in Asia[J]. Immunotherapy,2023,15(13):1029-1044.2证据水平1b。
科研之友
微信
新浪微博
Facebook
分享链接
